4 October 2016 - For other questions, an additional benefit has not been established. ...
4 October 2016 - Study evaluations unsuitable for statements about the positive or negative effects over comparative therapies. ...
21 September 2016 - CADTH is calling for patient input on a resubmission from Novo Nordisk for Victoza (liraglutide). ...
1 September 2016 - The 1 September 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
25 August 2016 - CADTH has published its final recommendation on the reimbursement of Invokamet in Canada. ...
14 August 2016 - Thousands of Australians with type 2 diabetes mellitus will soon be able to have one injection a ...
10 August 2016 - CADTH is undertaking a project to assess the clinical and cost-effectiveness of new drugs for the treatment ...
16 July 2016 - Diabetes drugs cost the NHS in Scotland almost £90 million last year amid fears that public health ...
24 May 2016 - The three drugs can all be used on their own if a person can’t use metformin or ...
30 March 2016 - CADTH has received notice of a pending submission from Boehringer Ingelheim for empagliflizin (Jardiance) for use by ...
22 February 2016 - A proposed CADTH project scope on new drugs for type 2 diabetes mellitus: a therapeutic review update ...
3 February 2016 - CADTH has received notice of a pending submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride for ...
1 December 2015 - CADTH has received notice of a pending submission from AstraZeneca for Xigduo (dapagliflozin propanediol monohydrate with metformin ...
16 November 2015 - The manufacturer presented no relevant data for the assessment of the added benefit of insulin degludec/liraglutide versus ...
17 November 2015 - CADTH has received notice of a pending submission from Eli LIlly for dulaglutide (Trulicity) for use by ...